Biotechnology Contract Manufacturing Market Key Highlights:
- Market Size (2024): USD 17.75 Billion
- Projected Market Size (2034): USD 41.63 Billion
- CAGR (2023-2034): 8.9%
Pricing Analysis:
- Price Growth
- Regional Variations
Market Historic Sales
- Total sales volume, year-over-year growth, product categories, and market share.
Revenue Estimation
- Forecasting future revenues based on historical data, market trends, and economic indicators.
Sales by Region
- Breakdown of sales performance across different geographical areas.
Revenue by Manufacturer
- Analysis of revenue contributions from different manufacturers in the market.
Biotechnology Contract Manufacturing Market Definition
Demand in the biotechnology contract manufacturing market is rising due to demand for biologics in medicine. Biologics contract manufacturers know how to make these therapies more effective with ease of use. Also, they ensure adherence to strict quality rules and regulations. They have a deep understanding of cell structure, downstream process, protein chemistry and its impact on yield and protein structure while forwarding from lab to GMP scale. Hence, biopharmaceutical companies prefer to go for highly efficient way to increase development and manufacturing by partnering with CDMOs, and CMOs. As they have strong expertise in biologics and commercial manufacturing. However, saving and protecting intellectual property can be a concern for companies. It includes the risk of using the patented information in an unauthorized way that creates a barrier to markets growth.
Although, increasing demand for cell and gene therapies are creating significant impact on the market, since gene and cell therapies are highly specific and hold potential to explore unidentified medical needs, further creating lucrative opportunities for the biotechnology contract manufacturing market on a global scale.
Biotechnology Contract Manufacturing Market Segmentation:
By Type
- Biologic Drug Substance Manufacturing
- Biologic Drug Product Manufacturing
By Application
- Monoclonal Antibodies
- Cell Therapy & Gene Therapy
- Antibody-Drug Conjugates (ADCs)
- Vaccines
- Therapeutic Peptides & Proteins
- Others
Biotechnology Contract Manufacturing Market Companies:
- Lonza
- Thermo Fisher Scientific Inc.
- Catalent Inc.
- Samsung Biologics
- WuXi Biologics
- Boehringer Ingelheim International GmbH
- FUJIFILM Holding Corporation
- AbbVie Inc.
- Eurofins Scientific
- AGC Inc.
- Merck KgaA
For any questions about this dataset or to discuss customization options, please write to us at sales@statifacts.com
